Adult Lymphoma — Trials

Adult Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

263 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 31
Recruiting: 17
Ph III recruiting: 2
Growth YoY: —
Industry share: 19%
Top sponsor: City of Hope Medical Center
Termination share: 32.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (53)

clinicaltrialsPublishedShowing 151–155 of 155 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00118170	Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function	completed	Phase 1	150	National Cancer Institute (NCI)NIH	1	Jan 7, 2013	clinicaltrials
NCT00061048	Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma	completed	Phase 2	29	National Cancer Institute (NCI)NIH	1	Oct 31, 2012	clinicaltrials